Listed

Xtant Medical Holdings, Inc.: Form 10-Q for the period ended Sep 30, 2015

Filed with the SEC on Nov 16, 2015 and accepted by EDGAR at Nov 16, 2015, 07:30 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2015-07-01 to 2015-09-30$17.7mus-gaap:SalesRevenueNet
Revenue9 months2015-01-01 to 2015-09-30$37.1mus-gaap:SalesRevenueNet
Cost of revenue3 months2015-07-01 to 2015-09-30$6.0mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2015-01-01 to 2015-09-30$12.9mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2015-07-01 to 2015-09-30$11.7mus-gaap:GrossProfit
Gross profit9 months2015-01-01 to 2015-09-30$24.2mus-gaap:GrossProfit
Research and development3 months2015-07-01 to 2015-09-30$794.5kus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2015-01-01 to 2015-09-30$1.5mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2015-07-01 to 2015-09-30−$4.9mus-gaap:OperatingIncomeLoss
Operating income9 months2015-01-01 to 2015-09-30−$8.0mus-gaap:OperatingIncomeLoss
Interest expense3 months2015-07-01 to 2015-09-30$2.1mus-gaap:InterestExpense
Interest expense9 months2015-01-01 to 2015-09-30$4.9mus-gaap:InterestExpense
Net income3 months2015-07-01 to 2015-09-30−$6.7mus-gaap:NetIncomeLoss
Net income9 months2015-01-01 to 2015-09-30−$13.8mus-gaap:NetIncomeLoss
Diluted EPS3 months2015-07-01 to 2015-09-30−$0.64us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2015-01-01 to 2015-09-30−$1.70us-gaap:EarningsPerShareDiluted
Basic EPS3 months2015-07-01 to 2015-09-30−$0.64us-gaap:EarningsPerShareBasic
Basic EPS9 months2015-01-01 to 2015-09-30−$1.70us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2015-07-01 to 2015-09-3010,432,622 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2015-01-01 to 2015-09-308,100,226 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2015-01-01 to 2015-09-30−$9.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2015-01-01 to 2015-09-30$444.3kus-gaap:PaymentsToAcquireProductiveAssets
Cash and equivalentsAt period end2015-09-30$8.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2015-09-30$44.4mus-gaap:AssetsCurrent
Total assetsAt period end2015-09-30$126.2mus-gaap:Assets
Current liabilitiesAt period end2015-09-30$16.7mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2015-09-30$129.1mus-gaap:Liabilities
Long-term debtAt period end2015-09-30$44.3mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2015-09-30$53.2kus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2015-09-30−$2.8mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-15-065520. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.